Drugs / SN301A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06652243 | Nov 2024 → Oct 2026 expected | hepatocellular carcinoma | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SN301A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06652243 ↗ |
| Route | Intravenous | “SN301A intravenous infusions” NCT06652243 ↗ |